home / lobbying / lobbying_activities

lobbying_activities: 3674320

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id filing_uuid filing_type registrant_name registrant_id client_name filing_year filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
3674320 a116fa97-8cdf-4dfd-8d04-dda85d35d830 Q2 AARP 1694 AARP 2025 second_quarter PHA H.R. 1, One Big Beautiful Bill Act. S. 1862/ H.R. 946, the Optimizing Research Progress Hope And New Cures (ORPHAN Cures) Act. S. 832, the Ensuring Pathways to Innovative Cures (EPIC) Act of 2025. H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. No bill number. Discussed the Medicare drug price negotiation program. Discussed pharmacy benefit manager reforms. S. 229/ H.R. 3789, the Drug-Price Transparency for Consumers (DTC) Act of 2025. S. 1096, Preserving Access to Affordable Generics and Biosimilars Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1097, the Interagency Patent Coordination and Improvement Act of 2025. S. 1040, Drug Competition Enhancement Act. S. 1041, Affordable Prescriptions for Patients Act. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office   5120000 0 0 2025-07-21T08:02:45-04:00
Powered by Datasette · Queries took 28.474ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API